Publications

• Toxicology
  • Regulatory
  • Discovery
  • Stem Cell
  • Botulinum
  • Investigative-Special-Custom
• Pharmacokinetics
• Pharmacology
  • Ocular
  • Cardiovascular
  • Inflammation
  • Atherosclerosis
  • Arthritis-Immune Mediated
  • Metabolic and Bone
  • Anti-infective
  • Oncology
  • Stem Cell
  • Botulinum
  • Surgical-Custom-Special
• Dermatology
  • Toxicology Studies
  • Pharmacokinetics or Bioavailability Studies
  • Pharmacology and Efficacy Studies
• Ocular
  • Ocular Toxicology
  • Ophthlamic Pharmacokinetics
  • Ophthlamic Pharmacology & In Vivo
• Stem Cells
• Botulinum
• Histopathology
  • Laboratory Capabilities
  • Histochemical Staining
  • Pathology
  • Confocal Microscopy
  • Toxicology
  • Tissue Cross Reactivity
  • Immunohistochemistry
  • Devices, plastics, ground sections
  • Histomorphometry
  • Specialized Histology
  • Submitting a Study
  • Fee Schedule
  • Slide Gallery
• About CBI
  • Management Team
  • Scientific Advisors
  • Scientific Staff
  • Mission
  • Careers
  • Partners
  • Contact Us
• Events
• News
• Publications

CBI Publication List

• Cowley AB, Poage DW, Dean RR, Meschter CL, Ghoddusi M, Li Q, Sidhu H. 14-Day Repeat-Dose Oral Toxicity Evaluation of Oxazyme in Rats and Dogs. Int J Toxicol 29: 20-3, 2010.
• David C. Fritzinger DC, Dean R, Meschter C, Wong K, Halter R, Borlak J, St. John WD,  VogelCW.   Chapter: Complement Depletion with Humanized Cobra Venom Factor in a Mouse Model of Age-related Macular Degeneration. Eye Inflammation, 2010.
• Fritzinger DC, Dean R*, Won K, Halter R‡, BorlakJ‡,St. John W, Vogel C: Complement depletion with humanized cobra venom factor reduces tissue damage in a mouse model for age-related macular degeneration. First International Conference on Inflammation and Retinal Disease: Complement Biology and Pathology, June 26-July 1, 2009.  Cancer Research Center of Hawaii, Honolulu, HI 96813, USA, *Comparative Biosciences, Inc, Sunnyvale, CA 94085, USA, ‡Center for Medical Biotechnology, Fraunhofer Institute for Toxicology and Aerosol Research, 30625 Hannover, Germany, Incode Biopharmaceutics, Inc., San Diego, CA 92121, USA.
• Sa.37. Control of Autoimmune Diseases By Epitope Specific Immunotherapy.  Billtta R, Omori M,  Kaspar A, Ghahramani N,  Brigham B, Meschter C,  Lanza P,  Albani S Clinical Immunology, Volume 119, Supplement 1, 2006, Page S118
• Miller Q, Meschter C, Neumaster T, Pratt J, Moulton M, Downey D, Harre J.Comparison of pleurodesis by erythromycin, talc, doxycycline, and diazepam in a rabbit model. J Surg Educ. 2007 Jan-Feb;64(1):41-5
• Moon Jong Noh, R. Ogden Copeland, Dug Keun Lee, Youngsuk Yi, Kyoung Back Choi, Carol Meschter, Sally Hwang, Chae-Lyul Lim, Vivian Yip Jong-Pil Hyun, Hyeon-Youl Lee, Kwan Hee Lee, Preclinical studies of retrovirally transduced human chondrocytes expressing TGF-1 (TG-C). J Ortho Research, Accepted, 2008.
• Miller Q, Bird E, Meschter C, Moulton, MJ: Effect of subatmospheric pressure on the acute healing wound.  CurrSurg 61:2, 205-08, 2004.
• Horais KA, Hruby V, Rossi P, Cizkova D, Meschter C, Dorr, R, Yaksh TL: Effects of chronic intrathecal infusion of a d-opioid agonist in dogs.  Toxicologic Sciences 71: 263-275, 2003.
• Yaksh TL, Horais KA, Tozier N, Allen, JW, Rathburn M, Meschter C, Richter P, Rossi S, Tong C, Cline J, Eisenach J: Intrathecal ketorolac in dogs and rats.  Anesthesiology, 2003.
• Yaksh TL, Horais KA, Tozier N, Allen, JW, Rathburn M, Richter P, Rossi S, Summer, C, Meschter C, Richter PJ, Hildebrand, KR: Chronically infused Intrathecal morphine in dogs.  Anesthesiology, 2002.
• Berryman L, Zerouala C, Meschter C, Spenard J: Intra-Rectal Administration of 5-Aminosalicylic Acid to Rabbits and Dogs, Accepted for Publication, 2001
• Richard B, Meschter CL, Reading C, Orlinska U, Ahlem C: Effects of AET on microscopic lesions of ulcerative colitis in a rat model of inflammatory bowel disease.  Accepted for Publication, 2001.
• Yaksh TL, Horais KA, Tozier N, Rathburn M, Meschter C, Richter P, Rossi S, Tong C, Cline M, Eisenbach J: Intrathecal ketorolac in dogs and rats.  DrugDevRes, 2001.
• Haberberger TC, Meschter CL, Murphy JE: Ectopic expression of connective tissue growth factor causes fibrosis in mouse lung.  Accepted for publication, AmJRespCellMolBio. 2001.
• Chaing TR, Fanget L, Gregory R, Tang Y, Ardiet DL, Gao L, Meschter CL Kozikowski AP, Bueow R, Vuist WM: AntiGAL antibodies in humans and 1, 3a-Galactosyltranferase knockout mice. Transplantation: 69(12):2593-2600, 2000
• Kelly KJ, Tolkoff-Rubin NE, Rubin RH, Williams, WW, Meehan SM, Meschter CL, Christenson JG, Bonventre JV:  An oral platelet activating factor Ro 24-4736 protects the rat kidney from ischemic injury.  AmJPhysiol: 271:(5Pt2) F1061-7, 1996.
• Van Zee K, Moldawer LL, Oldenburg SA, Thompson. WA, Stackpole SA, Montegu WJ, Rogy MA, Meschter CL, Gallati H Schiller, C, Richter W, Loetscher H, Charmow S, Wurm F, Calvano SE, Lowry SF, Lesslauer W: Protection against lethal E. coli bacteremia in baboons (Papio anubis) by pretreatment with a 55kDa TNF receptor (CD120a)-immunoglobulin fusion protein, Ro45-2081, JImmunol:156(6):221-30, 1996
• Stefanovic-Racic M, Meyers KP, Meschter CL, Coffey JW, Hoffman RA, Evans CW: Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapetic agents in rat adjuvant arthritis. J Rheumatology 22:10, 1922-1928, 1995
• Meschter CL, Kaufman L, Davidovitch A, Mortillo M, Garland WA, Mico BA: 13-week toxicologic evaluation of the effects of cytochromes P450 inhibition by 1-aminobenzotriazole in male CRD:CD rats. J Fund Appl Tox 22:369-381, 1994
• Evans CH, Meyers KP, Meschter CL, Coffey JW, Hoffman R, Stefanovic-Racic M: N-monoarginine, an inhibitor of nitric oxide synthase, suppresses the onset of adjuvant arthritis in rats. Arthritis and Rheumatism, 37(7): 1062-169, 1994
• Van Zee KJ, Stackpole SA, Montegut WJ, Rogy MA, Calvano SE, Hsu KC, Chao M, Meschter CL, Loetscher H, Stüber D, et al. A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon. J Exp Med. 1994 Apr 1;179(4):1185-91
• Van Zee K, Moldawer LL, Stackpole SA, Montegu WJ, Rogy MA, Meschter CL, Loetscher H, Brockhaus M, Wurm F, Calvano SE, Lowry SF, Lesslauer W: Protection against lethal E. coli septic shock in baboons by pretreatment with novel TNF inmmunoadhesions. J Exp Med, 179:1185-1191, 1994
• Conoway, C, Upadhyaya P, Meschter, CL, El-Bayoumy,K: Subchronic toxicity of benzylselenocyanate (BSC) and 1,4-phenylenebis (metheylene) selenocyanate (XSC) in rats. J Fund Appl Tox 19:563-574, 1992
• Weyand, EH, Defauw, J, Meegala, SK, McQueen, CA, Meschter, CL, LaVoie EJ, Bioassay of quinoline, 5-fluoroquinoline, carbazole and alkylcarbazoles in newborn mice. Food Chem Toxicol 31:707-713, 1993
• LaVoie EJ, Defauw J, McQueen, CA, Meschter CL, Weyand, EH: Bioactivation of Quinoline to a Hepatocarcinogen. Proceedings, 13th Annual Symposium on Polynuclear Aromatic Hydrocarbons, Bordeaux, France, October 1-4, 1991 
• Inhibition of Laser-Induced Choroidal Neovascularization in Rats by Soluble Complement Receptor Type 1 (TP10, sCR1).  Thomas LL,  Meschter C,  Cook CS, Fava G, Hammond RA, Rittershaus CW,  Marsh CH. ARVO Poster Presentation 2007 Annual Meeting, May 6 – May 10, 2007 Fort Lauderdale, Florida.
• Richard B, Meschter CL, Reading C, Orlinska U, Ahlem C: Effects of AET on microscopic lesions of ulcerative colitis in a rat model of inflammatory bowel disease.  The Cytokine Odyssey, Society for Leukocyte Biology and the International Cytokine Society, Maui, HA, 8-11November 2001.
• Auci D, Orlinska U, Richard B, Schwartz A, Meschter C, Ahlem C, Morgan E, Reading C: HE2500, a stable synthetic derivitive of DHEA, significantly reduces or eliminates lesions in a murine model of psoriaisis. 3rd International Congress on Autoimmunity, Geneva, Switzerland, 20-24 February, 2002.
• Destache CJ, Pakiz, DB, Dash AK, Larsen C, Meschter. Cytopathology and nitric oxide (NO) concentrations in an experimental model of Streptococcus pneumonia meningitis. ICAAC, Toronto, 1997 
• Tartaglia J, Schultz G, Meschter C et al.  Experimental models of vein closure with a thermal device.  Natl Soc Phlebology. Annual Meeting. Palm Springs. Nov 1997
• Griffith D, Annamalai T, Bond SM, Hecker SJ, McCallig L, Parr TR, Williams, Meschter CL, Lee V: In Vivo Pharmacology of MC-02,331, a New Cephalosporin Active Against Resistant Gram-Positive Organisms. ICAAC, New Orleans, 1996
• Griffith D, Annamalai T, Bond SM, Harford L, Williams R, Meschter CL, Lee V:  Efficacy of MC-02, 479, a New Cephalosporin, in the treatment of experimental murine infections due to gram-positive bacteria. ICAAC, Toronto, 1997
• Thomas, TK, Meschter, CL, Nwachuku, UA, Descarfino, J, Will, PC: Attenuation of platelet activating factor induced inflammation and E-selectin expression in rabbit skin by a PAF antagonist. 7th Int Conf, IRA, Sept 25-29, 1994
• Meschter, CL, VanZee K, Moldawer, L, Lowry, S, Lesslauer, W. Tumor necrosis factor receptor fusion protein protects against E. Coli-induced septic shock pathology in baboons. Advances in Sepsis and Endotoxemia, June 17, 18, 1993, Philadelphia, Pa. Poster.
• Evans, CH, Meyers, KP, Meschter CL, Coffey, JW, Hoffman, R, Stefanovic-Racic, M: N-monoarginine, an inhibitor of nitric oxide synthase, suppresses the onset of adjuvant arthritis in rats. International Congress on Inflammation, Vienna, Austria, October, 1993   
• Stefanovic-Racic, M, Coffey, JW, Meyers, KP, Meschter. CL, Hoffman, R: N-monoarginine, an inhibitor of nitric oxide synthase, suppresses the onset of adjuvant arthritis in rats. ACR, San Antonio, Texas. November, 1993
• Stefanovic-Racic, M, Meyers, KP, Meschter, CL, Coffey, JW, Hoffman, R: Inhibition of nitric oxide blocks the onset of adjuvant arthritis in rats. Transactions of the Orthopedic Research Society, Vol 19: 268, 1994
• Wolitzky, BA, Burns DK, Goldstein AL, Unowsky J, Meschter, CL, Harbison ML: The role of E-selectin in leukocyte migration in animal models of inflammation. EMBO Workshop on Leukocyte Homing and Differentiation, Nov 1-4, 1992, Basel Institute of Immunology, Abstract
• Yagaloff, KA, Xie, F, Meschter, CL, Rosenberg, M: Thapsigargan-induced leukotriene B4 production in human skin and dermal equivalents. American Society for Cell Biology, Denver, Co, Nov 15-19, 1992, Poster
• Yagaloff, KA, Franco, L, Meschter, CL: Leukotriene B4-induced skin inflammation is modulated in the ovalbumin-induced wheal response in ovalbumin-sensitized guinea pig. Inflammation Research Meeting, White Haven, PA Sept 20-24, 1992, Poster
• Meschter, CL., Harbison, M, Unowsky, J, McIntyre, K, Wolitzky, B: Histopathologic features, cytokine production and expression of E-selectin in endotoxin induced meningitis in the rabbit. American College of Veterinary Pathology, Annual Convention, San Diego, Ca, November, 1992
• Unowsky, J, Meschter, CL, Malagone, C, Kowal, K, Halpern, K: The role of platelet activating factor in an endotoxin-induced rabbit model of inflammatory meningitis Abstract, Keystone Conference "Biology of Endotoxins" Lake Tahoe, Ca, March 1-8, 1992
• Inoue, T, Anderson TD, Meschter, CL, Hayes, T: Immunotoxicological alterations induced by N-trimethoxybenzoyl-5'-Deoxy-5-Fluorcytidine Neofurtulon and 5'-Deoxy-5-Fluorouridine (Furtulon) in FD1 Mice. Abstract
• Yagaloff, KA, Suarez S, Meschter, CL: Leukotriene B4-induced leukocyte accumulation in the guinea pig. FASEB, Anaheim, Ca. April 1992. Poster
• Will PC, Unowsky J, Meschter, CL, Srivastava, A, Buckman DK: Effect of a platelet activating factor antagonist on eicosanoid metabolism in an endotoxin-induced rabbit model of inflammatory meningitis. FASEB, Anaheim, Ca., April, 1992. Poster
• Meschter, CL, Kaufman, L, Davidovitch, A, Mortillo, M, Garland, WA, Mico, BA: 13-week toxicologic evaluation of the effects of cytochrome p-450 inhibition by 1-aminobenzotriazole in male CRD:CD rats. Abstract. Society of Toxicology Annual Meeting, Seattle, Wa. February, 1992. Poster
• Inoue, T, Anderson TD, Meschter, CL, Hayes, TJ: Immunotoxicological alterations induced by N-trimethoxybenzoyl-5'-Deoxy-5-Fluorcytidine (Neofurtulon and 5'-Deoxy-5-Fluorouridine (Furtulon) in BFD1 Mice. Abstract. Society of Toxicology Annual Meeting, Seattle WA. February, 1992. Poster
• Conoway, C, Upadhyaya P, Meschter, CL, El Bayoumy K Subchronic toxicity of benzylselenocyanate (BSC) and 1,4-phenylenebis (metheylene) selenocyanate (XSC) in rats. Abstract. Society of Toxicology Annual Meeting, Seattle WA. February, 1992. Poster
• LaVoie E.J., Defauw J., McQueen, C.A., Meschter C. L., Weyand, E.H. Bioactivation of Quinoline to a Hepatocarcinogen. Proceedings, 13th Annual Symposium on Polynuclear Aromatic Hydrocarbons, Bordeaux, France, October 1-4, 1991. Platform presentation, Dr. Lavoie
• Unowsky, J., Meschter, C. L., Malagone, C., Kowal, K. Halpern, K.: The role of platelet activating factor in an endotoxin-induced rabbit model of inflammatory meningitis. Abstract, Keystone Conference "Biology of Endotoxins" Lake Tahoe, Ca, March 1-8, 1992 J. Cellular Biology, Abstract Supplement 16C: 168, 1992. Poster
• Meschter, C. L., Unowsky, J., Malagone, C., Kowal, K. Halpern, K.: Evaluation and characterization of endotoxin-induced meningitis model in the rabbit. Abstract, American College of Veterinary Pathologists Annual Meeting, Orlando Fl, December 8-13, 1991. Platform presentation
• Rose, D. P., Connolly, J. M., Meschter, C. L.: Effect of Dietary Fat on Human Breast Cancer Cell Growth and Metastasis in Nude Mice. Abstract. 14th Annual Breast Cancer Meeting, San Antonio, Texas, December 6-7, 1991